ATE94877T1 - Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe. - Google Patents
Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe.Info
- Publication number
- ATE94877T1 ATE94877T1 AT88306584T AT88306584T ATE94877T1 AT E94877 T1 ATE94877 T1 AT E94877T1 AT 88306584 T AT88306584 T AT 88306584T AT 88306584 T AT88306584 T AT 88306584T AT E94877 T1 ATE94877 T1 AT E94877T1
- Authority
- AT
- Austria
- Prior art keywords
- hypoglykaemical
- isosteres
- purines
- agents
- piperazinyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7536287A | 1987-07-20 | 1987-07-20 | |
| EP88306584A EP0300726B1 (de) | 1987-07-20 | 1988-07-19 | Piperazinylderivate von Purinen und deren Isostere als hypoglykämische Wirkstoffe |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE94877T1 true ATE94877T1 (de) | 1993-10-15 |
Family
ID=22125206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88306584T ATE94877T1 (de) | 1987-07-20 | 1988-07-19 | Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0300726B1 (de) |
| JP (1) | JP2562181B2 (de) |
| KR (1) | KR890002155A (de) |
| AT (1) | ATE94877T1 (de) |
| AU (1) | AU601862B2 (de) |
| CA (1) | CA1341043C (de) |
| DE (1) | DE3884304T2 (de) |
| DK (1) | DK403188A (de) |
| ES (1) | ES2058291T3 (de) |
| FI (1) | FI883423L (de) |
| HU (1) | HU199144B (de) |
| IL (1) | IL87149A (de) |
| NO (1) | NO167203C (de) |
| NZ (1) | NZ225447A (de) |
| PT (1) | PT88029B (de) |
| YU (1) | YU46761B (de) |
| ZA (1) | ZA885242B (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86007A0 (en) * | 1987-04-09 | 1988-09-30 | Wellcome Found | 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them |
| GB8716313D0 (en) * | 1987-07-10 | 1987-08-19 | Janssen Pharmaceutica Nv | 2-(heterocyclylalkyl)imidazopyridines |
| GB8922076D0 (en) * | 1989-09-28 | 1989-11-15 | Beecham Group Plc | Novel process |
| DK150591D0 (da) * | 1991-08-26 | 1991-08-26 | Novo Nordisk As | Kemisk forbindelse |
| FI943798A0 (fi) * | 1992-02-19 | 1994-08-18 | Pfizer | Kasvaimenvastaisen vaikutuksen lisäämiseen tarkoitettuja heterosyklisiä yhdisteitä |
| US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
| AU3053999A (en) | 1998-03-31 | 1999-10-25 | Kyowa Hakko Kogyo Co. Ltd. | Nitrogenous heterocyclic compounds |
| EP1499598A1 (de) | 2002-04-18 | 2005-01-26 | Ucb, S.A. | Chemische verbindungen mit zweiteiliger wirkung,verfahren zu deren herstellung und pharmazeutische zusammenstellungen |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| MXPA05005983A (es) | 2002-12-04 | 2005-08-18 | Eisai Co Ltd | Compuestos de anillo fusionado 1,3-dihidroimidazol. |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2005023253A1 (en) | 2003-09-05 | 2005-03-17 | Altana Pharma Ag | Use of pde4 inhibitors for the treatment of diabetes mellitus |
| ATE544765T1 (de) | 2003-12-22 | 2012-02-15 | Leuven K U Res & Dev | Imidazoä4,5-cüpyridinverbindungen und verfahren zur antiviralen behandlung |
| WO2006009736A1 (en) | 2004-06-17 | 2006-01-26 | Wyeth | Processes for preparing gonadotropin releasing hormone receptor antagonists |
| WO2006009734A1 (en) | 2004-06-17 | 2006-01-26 | Wyeth | Gonadotropin releasing hormone receptor antagonists |
| NZ556624A (en) | 2004-12-21 | 2010-06-25 | Gilead Sciences Inc | 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine and method of antiviral treatment |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| AU2006222060B2 (en) | 2005-03-08 | 2011-09-01 | Takeda Gmbh | Roflumilast for the treatment of diabetes mellitus |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| SG175604A1 (en) | 2006-07-07 | 2011-11-28 | Gilead Sciences Inc | Novel pyridazine compound and use thereof |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX2009013293A (es) | 2007-06-04 | 2010-02-15 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos. |
| UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
| EP2810951B1 (de) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase |
| JP2011527342A (ja) * | 2008-07-07 | 2011-10-27 | エックスカバリー ホールディング カンパニー エルエルシー | Ｐｉ３ｋアイソフォーム選択的阻害剤 |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| UA104010C2 (en) | 2008-12-18 | 2013-12-25 | Эли Лилли Энд Компани | Purine compounds |
| ES2665277T3 (es) * | 2009-03-13 | 2018-04-25 | Katholieke Universiteit Leuven K.U. Leuven R&D | Análogos de purina y su uso como agentes inmunosupresores |
| CA2795006C (en) | 2010-03-31 | 2014-05-13 | Eli Lilly And Company | Purine compounds used as cb2 agonists |
| AR080711A1 (es) | 2010-03-31 | 2012-05-02 | Lilly Co Eli | Compuesto de piperazin-purina composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento o prevencion del dolor |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CA3100941C (en) | 2011-03-01 | 2024-03-05 | Synergy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
| EP3718557A3 (de) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylat-cyclase-rezeptoragonist sp-333 zur verwendung in der darmreinigung |
| JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
| JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
| HUE039589T2 (hu) * | 2013-05-02 | 2019-01-28 | Hoffmann La Roche | Purinszármazékok mint CB2 receptor agonisták |
| EA201592263A1 (ru) | 2013-06-05 | 2016-05-31 | Синерджи Фармасьютикалз, Инк. | Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования |
| KR20160042039A (ko) | 2013-08-09 | 2016-04-18 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
| CN104497085B (zh) * | 2015-01-16 | 2017-05-24 | 华东理工大学 | 腺苷衍生物及其用途 |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1115260B (de) * | 1957-02-27 | 1961-10-19 | Thomae Gmbh Dr K | Verfahren zur Herstellung von Purinderivaten |
| GB1186504A (en) * | 1966-10-15 | 1970-04-02 | Fisons Pest Control Ltd | Substituted Heterocyclic Compounds |
| JPS60260579A (ja) * | 1984-01-13 | 1985-12-23 | Yoshitomi Pharmaceut Ind Ltd | プリン誘導体 |
| JPS6210085A (ja) * | 1985-07-05 | 1987-01-19 | Yoshitomi Pharmaceut Ind Ltd | トリフルオロメチルプリン誘導体 |
-
1988
- 1988-07-18 NZ NZ225447A patent/NZ225447A/en unknown
- 1988-07-18 IL IL8714988A patent/IL87149A/xx unknown
- 1988-07-19 DK DK403188A patent/DK403188A/da not_active Application Discontinuation
- 1988-07-19 NO NO883204A patent/NO167203C/no unknown
- 1988-07-19 FI FI883423A patent/FI883423L/fi not_active Application Discontinuation
- 1988-07-19 AU AU19230/88A patent/AU601862B2/en not_active Ceased
- 1988-07-19 ES ES88306584T patent/ES2058291T3/es not_active Expired - Lifetime
- 1988-07-19 CA CA000572450A patent/CA1341043C/en not_active Expired - Fee Related
- 1988-07-19 HU HU883774A patent/HU199144B/hu not_active IP Right Cessation
- 1988-07-19 AT AT88306584T patent/ATE94877T1/de not_active IP Right Cessation
- 1988-07-19 PT PT88029A patent/PT88029B/pt not_active IP Right Cessation
- 1988-07-19 EP EP88306584A patent/EP0300726B1/de not_active Expired - Lifetime
- 1988-07-19 DE DE88306584T patent/DE3884304T2/de not_active Expired - Fee Related
- 1988-07-20 JP JP63179325A patent/JP2562181B2/ja not_active Expired - Fee Related
- 1988-07-20 YU YU141088A patent/YU46761B/sh unknown
- 1988-07-20 ZA ZA885242A patent/ZA885242B/xx unknown
- 1988-07-20 KR KR1019880009044A patent/KR890002155A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2562181B2 (ja) | 1996-12-11 |
| IL87149A0 (en) | 1988-12-30 |
| PT88029A (pt) | 1989-06-30 |
| DK403188A (da) | 1989-03-30 |
| AU601862B2 (en) | 1990-09-20 |
| FI883423A0 (fi) | 1988-07-19 |
| DE3884304T2 (de) | 1994-03-24 |
| EP0300726A1 (de) | 1989-01-25 |
| DK403188D0 (da) | 1988-07-19 |
| DE3884304D1 (de) | 1993-10-28 |
| FI883423A7 (fi) | 1989-01-21 |
| NO883204D0 (no) | 1988-07-19 |
| FI883423L (fi) | 1989-01-21 |
| NO167203C (no) | 1991-10-16 |
| YU141088A (en) | 1990-10-31 |
| IL87149A (en) | 1994-05-30 |
| HUT47575A (en) | 1989-03-28 |
| JPH01104074A (ja) | 1989-04-21 |
| ES2058291T3 (es) | 1994-11-01 |
| NO167203B (no) | 1991-07-08 |
| AU1923088A (en) | 1989-01-27 |
| PT88029B (pt) | 1995-03-01 |
| KR890002155A (ko) | 1989-04-08 |
| ZA885242B (en) | 1989-03-29 |
| YU46761B (sh) | 1994-05-10 |
| NO883204L (no) | 1989-01-23 |
| HU199144B (en) | 1990-01-29 |
| EP0300726B1 (de) | 1993-09-22 |
| CA1341043C (en) | 2000-07-04 |
| NZ225447A (en) | 1991-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3884304D1 (de) | Piperazinylderivate von Purinen und deren Isostere als hypoglykämische Wirkstoffe. | |
| HUP0002373A2 (hu) | Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények | |
| NO875299L (no) | Insulinpreparat for ikke-paranteral administrasjon. | |
| DE3785684D1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| BE904421A (fr) | Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique. | |
| DE3686483D1 (de) | Arzneimittel. | |
| ATE163849T1 (de) | Arzneimittel enthaltend als wirkstoff r-alpha- liponsäure oder s-alpha-liponsäure | |
| DE69015842D1 (de) | Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE3588023D1 (de) | Mittel zur Behandlung von Herzerkrankungen. | |
| DE68906609D1 (de) | Dopamin-vorlaeufer. | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| ATE157007T1 (de) | 6-cyclohexyl-2'-0-methyl-adenosine hydrat und verwendungengen davon | |
| DE3881907D1 (de) | Phenoxycarbonsaeureverbindungen und diese als aktivsubstanz enthaltendes unkrautvertilgungsmittel. | |
| ATE183648T1 (de) | Arzneimittel enthaltend mischungen von höheren primären aliphatischen alkoholen zur behandlung von hypercholesterolämie und hyperlipoproteinämie typ ii und zur stimulation des sexuellen verhaltens bei tieren und menschen | |
| DE58902582D1 (de) | Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe. | |
| ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
| DK0402208T3 (da) | Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet | |
| ATE106732T1 (de) | Arzneimittelzubereitung, enthaltend stigmasta-4- en-3-on sowie deren verwendung. | |
| ATE139703T1 (de) | Aureobasidin enthaltendes arzneimittel | |
| DE69008282D1 (de) | Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE3484155D1 (de) | Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216. | |
| ATE175349T1 (de) | Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie | |
| KR890001555A (ko) | 요산 배설용 조성물 | |
| ATE72397T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |